Lakmini Kahanawita
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
Journal: The Lancet. Neurology
Published: July 09, 2025
Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 25, 2025
Multimodal markers of immune activation predict cognitive outcomes in Parkinson's disease.
Journal: Brain, behavior, and immunity
Published: January 15, 2025
Peripheral-central immune crosstalk in Parkinson's disease and its association with clinical severity.
Journal: Brain, behavior, and immunity
Published: November 13, 2024
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases.
Journal: Nature communications
Published: August 01, 2023
Natural killer cells have an activated profile in early Parkinson's disease.
Journal: Journal of neuroimmunology
Published: April 19, 2023
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade.
Journal: Nature communications
Published: June 29, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026